移到主要內容
:::

呂英震 副教授

呂英震 副教授
國立清華大學生命科學所博士
研究室分機:05-2717615
專  長: 
微生物學、分子生物學、蛋白質工程、發酵、保健食品開發應用、生物科技產業智慧財產權、生技產業發展
任教科目:微生物學
研究主題:1. 益生菌篩選與鑑定; 2.
 保健食品開發
E-mail:biolyc@mail.ncyu.edu.tw

教師研究成果


呂英震老師


現職
國立嘉義大學食品科學系暨研究所助理教授
勞動部勞動力發展署雲嘉南分署小型企業人力提升計畫輔導顧問
勞動部勞動力發展署雲嘉南分署雲嘉南區域運籌人力資源整合服務計畫輔導顧問
台南市中小企業服務團顧問
嘉義市市政顧問

經歷
國立嘉義大學檢驗分析及技術推廣服務中心主任
國立嘉義大學食品科學系食品加工廠主任
科技部補助生技機能性原料試量產製程技術聯盟協同主持人
教育部補助生技保健產品開發聯合技術發展中心協同主持人
中華醫事科技大學生物科技系暨生物醫學研究所助理教授
中華醫事科技大學機能性益生菌研發中心主任
中華醫事科技大學蛋白質核心服務中心主任

台灣科學工業園區同業公會產學合作與技術發展委員會召集人
中華民國南部科學園區產學協會通訊推廣委員會委員

景岳生物科技股份有限公司執行顧問
景岳生物科技股份有限公司研發長
景岳生物科技股份有限公司研發經理

中央研究院生物醫學科學研究所博士後研究

發表文獻Publications
  1. Chih-Feng Wang, Cui-Rou Huang, Ying-Chen Lu* (2023) Changes in the Bio-Compounds and Biological Activities of Eight Whole Grains Fermentation Starter with Different Oxidized Chin-Shin Oolong Teas. Foods 12(8):1643 doi: 10.3390/foods12081643.
  2. Chih-Feng Wang, Cui-Rou Huang, Ying-Chen Lu* (2023) Changes in Bio-Functional Compounds, ACE Inhibition, and Antioxidant Capacity after Mixed Fermentation of Eight Whole Grains. Fermentation 9:209. doi:10.3390/fermentation9030209
  3. Syue-Fong Lai, Yi-Wen Chen, Shin-Mei Lee, Hsin-Yu Huang, Yu-Hsin Huang, Ying-Chen Lu*, Chih-Wei Chen* (2023) Development and Optimization of Black Rice (Oryza sativa L.) Sourdough Fermented by Levilactobacillus brevis LUC 247 for Physicochemical Characteristics and Antioxidant Capacity. Foods 12(7):1389. doi: 10.3390/foods12071389.
  4. Wei-Kuang Lai, Yang-Chang Wu, Tai-Sheng Yeh, Chun-Ren Hsieh, Yi-Hong Tsai, Chien-Kei Wei, Chi-Ying Li, Ying-Chen Lu*, Fang-Rong Chang* (2022) The protoplast two-way fusions and fusant characteristics of Antrodia cinnamomea and Cordyceps militaris. Food science and human wellness 11(5):1240. doi: 10.1016/j.fshw.2022.04.032
  5. Chi-Chung Chen, Chih-Cheng Lai, Hui-Ling Huang, Yu-Ting Su, Yu-Hsin Chiu, Han-Siong Toh, Shyh-Ren Chiang, Yin-Ching Chuang, Ying-Chen Lu*, Hung-Jen Tang* (2021) Antimicrobial ability and mechanism analysis of Lactobacillus species against carbapenemase-producing Enterobacteriaceae. Journal of Microbiology, Immunology and Infection 54(3):447. doi: 10.1016/j.jmii.2020.01.005.
  6. Ko-Chao Lee, Kuen-Lin Wu, Chia-Kung Yen, Shun-Fu Chang, Cheng-Nan Chen*, Ying-Chen Lu* (2022) Inhibition of NLRP3 by Fermented Quercetin Decreases Resistin-Induced Chemoresistance to 5-Fluorouracil in Human Colorectal Cancer Cells. Pharmaceuticals (Basel) 15(7):798. doi: 10.3390/ph15070798. (Correspondence, SCI 5.215)
  7. Ko-Chao Lee, Chia-Kung Yen, Cheng-Nan Chen, Shun-Fu Chang, Ying-Chen Lu*, Wen-Shih Huang* (2021) Drug Resistance of CPT-11 in Human DLD-1 Colorectal Cancer Cells through MutS Homolog 2 Upregulation. International Journal of Medical Sciences 18(5):1269. doi: 10.7150/ijms.52620. (Correspondence, SCI 3.642)
  8. Chi-Chung Chen, Chih-Cheng Lai, Hui-Ling Huang, Wen-Yu Huang, Han-Siong Toh, Tzu-Chieh Weng, Yin-Ching Chuang, Ying-Chen Lu*, Hung-Jen Tang* (2019) Antimicrobial Activity of Lactobacillus Species Against Carbapenem-Resistant Enterobacteriaceae. Frontiers in Microbiology10:789. doi: 10.3389/fmicb.2019.00789. (Correspondence, SCI 6.064)
  9. Hung-Jen Tang, Chi-Chung Chen, Ying-Chen Lu, Hui-Ling Huang, Hung-Jui Chen, Yin-Ching Chuang, Chih-Cheng Lai, Chien-Ming Chao (2022) The effect of Lactobacillus with prebiotics on KPC-2-producing Klebsiella pneumoniae. Front Microbiol. 13:1050247. doi: 10.3389/fmicb.2022.1050247.
  10. Hung-Jen Tang, Yi-Tsung Lin, Chi-Chung Chen, Chih-Wei Chen, Ying-Chen Lu, Wen-Chien Ko, Hung-Jui Chen, Bo-An Su, Ping-Chin Chang, Yin-Ching Chuang, Chih-Cheng Lai (2021) Molecular characteristics and in vitro effects of antimicrobial combinations on planktonic and biofilm forms of Elizabethkingia anopheles. J Antimicrob Chemother. 76(5):1205-1214. doi: 10.1093/jac/dkab018.
  11. Wei-Kuang Lai, Ying-Chen Lu, Chun-Ren Hsieh, Chien-Kei Wei, Yi-Hong Tsai, Fang-Rong Chang, You Chan (2021) Developing Lactic Acid Bacteria as an Oral Healthy Food. Life (Basel) 11(4):268. doi: 10.3390/life11040268.
  12. Ming-Jen Sheu, Chi-Chung Chen, Ying-Chen Lu, Bo-An Su, Chun-Cheng Zhang, Shu-Shen Wang, Yin-Ching Chuang, Hung-Jen Tang, Chih-Cheng Lai (2020) In Vitro Antimicrobial Activity of Various Cefoperazone/Sulbactam Products. Antibiotics (Basel) 9(2):77. doi: 10.3390/antibiotics9020077.
  13. Po-An Su, Shun-Lai Li, Hung-Jen Tang, Chi-Chung Chen, Ying-Chen Lu, Kuo-Chen Cheng, Yi-Chung Lin, Yin-Ching Chuang, Chih-Cheng Lai (2020) In Vitro Synergy of Pongamia pinnata Extract in Combination with Antibiotics for Inhibiting and Killing Methicillin-Resistant Staphylococcus aureus. Antibiotics (Basel) 9(3):103. doi: 10.3390/antibiotics9030103.
  14. Te-Chuan Chen, Chia-Kung Yen, Ying-Chen Lu, Chung-Sheng Shi, Rong-Ze Hsieh, Shun-Fu Chang, Cheng-Nan Chen (2020) The antagonism of 6-shogaol in high-glucose-activated NLRP3 inflammasome and consequent calcification of human artery smooth muscle cells. Cell Biosci. 10:5. doi: 10.1186/s13578-019-0372-1.
  15. Chih-Wei Chen, Hung-Jen Tang, Chi-Chung Chen, Ying-Chen Lu, Hung-Jui Chen, Bo-An Su, Tzu-Chieh Weng, Yin-Ching Chuang, Chih-Cheng Lai (2019) The Microbiological Characteristics of Carbapenem-Resistant Enterobacteriaceae Carrying the mcr-1 Gene. J Clin Med. 8(2):261. doi: 10.3390/jcm8020261.
  16. Chih-Cheng Lai, Chi-Chung Chen, Ying-Chen Lu, Tsuey-Pin Lin, Hung-Jui Chen, Bo-An Su, Chien-Ming Chao, Yin-Ching Chuang, Hung-Jen Tang (2019) The Potential Role of Sulbactam and Cephalosporins Plus Daptomycin Against Daptomycin-Nonsusceptible VISA and H-VISA Isolates: An in Vitro Study. Antibiotics (Basel) 8(4):184. doi: 10.3390/antibiotics8040184.
  17. Chih-Cheng Lai, Chi-Chung Chen, Ying-Chen Lu, Hung-Jui Chen, Bo-An Su, Tzu-Chieh Weng, Yu-Hsin Chiu, Han-Siong Toh, Chun-Cheng Zhang, Shyh-Ren Chiang, Yin-Ching Chuang, Hung-Jen Tang (2018) Simultaneous three Enterobacteriaceae with different bla NDM-1-encoding plasmids in a patient transferred from mainland China to Taiwan. Infect Drug Resist. 11:2555-2560. doi: 10.2147/IDR.S179024.
  18. Chih-Cheng Lai, Chi-Chung Chen, Ying-Chen Lu, Tsuey-Pin Lin, Yin-Ching Chuang, Hung-Jen Tang (2018) Appropriate composites of cefoperazone-sulbactam against multidrug-resistant organisms. Infect Drug Resist. 11:1441-1445. doi: 10.2147/IDR.S175257.
  19. Chih-Cheng Lai, Chi-Chung Chen, Ying-Chen Lu, Yin-Ching Chuang, Hung-Jen Tang (2018) In vitro activity of cefoperazone and cefoperazone-sulbactam against carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa. Infect Drug Resist. 12:25-29. doi: 10.2147/IDR.S181201.
  20. Chih-Cheng Lai, Chi-Chung Chen, Ying-Chen Lu, Yin-Ching Chuang, Hung-Jen Tang (2018) The clinical significance of silent mutations with respect to ciprofloxacin resistance in MRSA. Infect Drug Resist. 11:681-687. doi: 10.2147/IDR.S159455.
  21. Ping-Chin Chang, Chi-Chung Chen, Ying Chen Lu, Chih-Cheng Lai, Hui-Ling Huang, Yin-Ching Chuang, Hung-Jen Tang (2018) The impact of inoculum size on the activity of cefoperazone-sulbactam against multidrug resistant organisms. J Microbiol Immunol Infect. 51(2):207-213. doi: 10.1016/j.jmii.2017.08.026.
  22. Nguyen Xuan Hoang, Sophia Ferng, Ching-Hua Ting, Ying-Chen Lu, Yu-Fong Yeh, Yi-Ru Lai, Robin Yih-Yuan Chiou, Jean-Yu Hwang, Cheng-Kuang Hsu∗, (2018) Effect of initial 5 days fermentation under low salt condition on the quality of soy sauce. LWT - Food Science and Technology 92:234–241. doi: 10.1016/j.lwt.2018.02.043
  23. J-K Jhan, Y-C Chung, G-H Chen, C-H Chang, Y-C Lu, C-K Hsu (2016) Anthocyanin contents in the seed coat of black soya bean and their anti-human tyrosinase activity and antioxidative activity. Int J Cosmet Sci 38(3):319-24. doi: 10.1111/ics.12300.
  24. Yi-Heng Chiu, Shiao-Lin Lin, Chu-Chyn Ou, Ying-Chen Lu, Hsin-Yu Huang, Meei-Yn Lin, (2013) Anti-inflammatory effect of lactobacilli bacteria on HepG2 cells is through cross-regulation of TLR4 and NOD2 signalling. J Funct Foods. 5 (2013) 820–828. doi: 10.1016/j.jff.2013.01.028
  25. Feng-Ching Hsieh, Chia-Lin Lee, Chee-Yin Chai, Wan-Tzu Chen, Ying-Chen Lu, and Ching-Shuang Wu (2013) Oral administration of Lactobacillus reuteri GMNL-263 improves insulin resistance and ameliorates hepatic steatosis in high fructose-fed rats. Nutr Metab (Lond). 10: 35. doi: 10.1186/1743-7075-10-35
  26. Yuh-Feng Wang, Hsin-Yu Huang, Yung-Wei Chiu, Wei-Hsun Chao, Tzyy-Ling Chuang, Ying-Chen Lu, Meei-Yn Lin (2012) Evaluation of Multi-strain Lactobacillus Capsule on Gastric Emptying Function by Tc-99m Scintigraphy in a Crossover Placebo-Controlled Clinical Trial. Journal of Food and Drug Analysis, 20, 653. doi:10.6227/jfda.2012200312
  27. Hsiao-Wei Chen, Tsung-Shi Yang, Mao-Jing Chen, Yu-Ching Chang, Chai-Yi Lin, Eugene I-Chen Wang, Chen-Lung Ho, Kue-Ming Huang, Chi-Cheng Yu, Feng-Ling Yang, Shih-Hsiung Wu, Ying-Chen Lu, Louis Kuop-Ping Chao (2012) Application of power plant flue gas in a photobioreactor to grow Spirulina algae, and a bioactivity analysis of the algal water-soluble polysaccharides. Bioresour Technol. 120:256-63. doi: 10.1016/j.biortech.2012.04.106.
  28. Hsueh-Fang Wang, Chien-Yu Tseng, Mu-Hsin Chang, James A Lin, Fu-Jen Tsai, Chang-Hai Tsai, Ying-Chen Lu, Chao-Hung Lai, Chih-Yang Huang, Cheng-Chih Tsai (2012) Anti-inflammatory effects of probiotic Lactobacillus paracasi on ventricles of BALB/C mice treated with ovalbumin. Chin J Physiol. 55(1):37-46. doi: 10.4077/CJP.2012.AMM107.
  29. Li-Te Yin, Ya-Ting Lin, Ying-Chen Lu, Chih-Yu Hu (2010) Enzyme immobilization on nitrocellulose film for pH-EGFET type biosensors. Sensors Actuators: B. Chemical, 148, 207. doi:10.1016/j.snb.2010.04.042
  30. Ying-Chen Lu, Li-Te Yin, Wen-Teng Chang, Jau-Shyang Huang (2010) Effect of Lactobacillus reuteri GMNL-263 treatment on renal fibrosis in diabetic rats. J Biosci Bioeng. 110(6):709-15. doi: 10.1016/j.jbiosc.2010.07.006.

中華民國發明專利Patents(專利權人屬國立嘉義大學)
  1. I671013優格冰淇淋及其製作方法
  2. I607711植物性凝態優格及其製造方法
  3. I599364預防或減緩糖尿病及其併發症的大豆醱酵產物及其應用

其他專利 Other Patents(專利權人非屬國立嘉義大學)
  1. (發明) Tu-Wen Yu, Jun-Sheng Li, Fen-Ching Hsieh, Ching-Pei Chen, Tsuei-Yin Huang, Ying-Chen Lu, “Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same” US 7901926
  2. (發明) Ching-Hsiang Hsu, and Ying-Chen Lu, " Microorganism strain GM-090 of Lactobacillus fermentum and its use for stimulating IFN-gamma secretion and/or treating allergy", US7351572 
  3. (發明) Tu-Wen Yu, Jun-Sheng Li, Fen-Ching Hsieh, Ching-Pei Chen, Tsuei-yin Huang, Ying-Chen Lu, “Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same (GMNL-76)” EP2116594
  4. (發明) Ching-Hsiang Hsu, and Ying-Chen Lu, " NEW MICROORGANISMAL STRAIN GM-090 OF LACTOBACILLUS FERMENTUM, AND ITS USE FOR STIMULATING IFN-gamma SECRETION AND/OR TREATING ALLERGY ", JP4823503
  5. (發明) Du Wen Yu, Jun Sheng Li, Feng Qin Xie, Liang Pei Chen, Zui Yin Huang, Ying Zhen Lu, “Lactobacillus separation strains with anti-inflammatory activity and application thereof (GMNL-76) “, 851562/CN101575582B
  6. (發明) Ching-Hsiang Hsu, and Ying-Chen Lu, " Microorganism strain GM-090 of lactobacillus fermentum and its use for stimulating INF-gamma secretion and/or treating allergy ", 337946/CN1329505C
  7. (發明) 呂英震、黃昭祥、謝豐欽、李易丞、李佳玲,益生菌株GM-263 (ADR-1)用於治療糖尿病引發之腎纖維化的組合物及其用途。I355939 
  8. (發明) 俞篤文,李濬笙,謝豐欽,陳靚珮,黃璻尹,呂英震,具有抗發炎活性的乳桿菌分離株及其用途(GMNL-89),I346554 
  9. (發明) 呂英震,謝豐欽,新穎乳桿菌、其組合物、及彼等於改善糖尿病及其併發症之用途,I340021
  10. (發明) 許清祥、呂英震,新穎微生物株醱酵乳酸桿菌GM-090及其刺激INF-g分泌及/或治療過敏之用途,I319780。 
  11. (新型) 呂英震,林聖文,具減緩心臟發炎功效之乳酸菌口服微粒結構,M405267
  12. (新型) 呂英震,謝豐欽,林聖文,具減緩糖尿病症狀功效之乳酸菌口服微粒結構,M405270
  13. (新型) 呂英震,林聖文,具牙齒保健功效之乳酸菌口服微粒結構,M405271
  14. (新型) 呂英震,謝豐欽,陳俐吟,林聖文,女性保健用的口服微粒,M397903 
  15. (新型) 呂英震,謝豐欽,陳俐吟,林聖文,具有護肝功效的口服微粒,M396124
  16. (發明) Tu-Wen Yu, Jun-Sheng Li, Fen-Ching Hsieh, Ching-Pei Chen, Tsuei-yin Huang, Ying-Chen Lu, “Lactobacillus isolated strain having anti-inflammatory activity a nd use thereof” JP2009269906 (A) 
  17. (發明) DuWen Yu, JunSheng Li, FengQin Xie, LiangPei Chen, ZuiYin Huang, YingZhen Lu, “Lactobacillus separation strains with anti-inflammatory activity and application thereof (GMNL-89) “, 201010567585.7 
  18. (發明) Ying-Chen Lu, and Ching-Hsiang Hsu, “Novel  Lactobacillus Strain,Composition and Use Thereof for Improving the Syndrome of Diabetes and Complication Thereof”, CN201010205942.5 
  19. (發明) Ying-Chen Lu, and Ching-Hsiang Hsu, “Novel Lactobacillus Strain,Composition and Use Thereof for Improving the Syndrome of Diabetes and Complication Thereof”, EP10164646.1 
  20. (發明) Ying-Chen Lu, and Ching-Hsiang Hsu, “Novel Lactobacillus Strain,Composition and Use Thereof for Improving the Syndrome of Diabetes and Complication Thereof”, JP2010-130974 
  21. (發明) Ying-Chen Lu, and Ching-Hsiang Hsu, “Novel Lactobacillus Strain,Composition and Use Thereof for Improving the Syndrome of Diabetes and Complication Thereof”, US 12/792276 
  22. (發明) Ying-Chen Lu,  Ching-Hsiang Hsu, Cheng-Chih Tsai, Chih-Yang Huang, Hsueh-Fang Wang, Chien-Yu Tseng, “USE OF PROBIOTIC STRAIN GM-080 IN TREATING CARDIAC INFLAMMATION AND APOPTOSIS”, CN201010276607.4 
  23. (發明) Ying-Chen Lu,  Ching-Hsiang Hsu, Cheng-Chih Tsai, Chih-Yang Huang, Hsueh-Fang Wang, Chien-Yu Tseng, “USE OF PROBIOTIC STRAIN GM-080 IN TREATING CARDIAC INFLAMMATION AND APOPTOSIS”, DE102010060693.6 
  24. (發明) Ying-Chen Lu,  Ching-Hsiang Hsu, Cheng-Chih Tsai, Chih-Yang Huang, Hsueh-Fang Wang, Chien-Yu Tseng, “USE OF PROBIOTIC STRAIN GM-080 IN TREATING CARDIAC INFLAMMATION AND APOPTOSIS”, FR1150235 
  25. (發明) Ying-Chen Lu,  Ching-Hsiang Hsu, Cheng-Chih Tsai, Chih-Yang Huang, Hsueh-Fang Wang, Chien-Yu Tseng, “USE OF PROBIOTIC STRAIN GM-080 IN TREATING CARDIAC INFLAMMATION AND APOPTOSIS”, GB10199556.8 
  26. (發明) Ying-Chen Lu,  Ching-Hsiang Hsu, Cheng-Chih Tsai, Chih-Yang Huang, Hsueh-Fang Wang, Chien-Yu Tseng, “USE OF PROBIOTIC STRAIN GM-080 IN TREATING CARDIAC INFLAMMATION AND APOPTOSIS”, JP2010-291410 
  27. (發明) Ying-Chen Lu,  Ching-Hsiang Hsu, Cheng-Chih Tsai, Chih-Yang Huang, Hsueh-Fang Wang, Chien-Yu Tseng, “USE OF PROBIOTIC STRAIN GM-080 IN TREATING CARDIAC INFLAMMATION AND APOPTOSIS”, US12/947829 
  28. (發明) Ying-Chen Lu, and Ching-Hsiang Hsu, COMPOSITION AND USE OF LACTOBACILLUS PARACASEI STRAIN GMNL-133 IN TREATING ATOPIC DERMATITIS OR OTHER ALLERGIC DISEASES, US13/273,228 
  29. (發明) Tu-Wen Yu, Jun-Sheng Li, Fen-Ching Hsieh, Ching-Pei Chen, Tsuei-yin Huang, Ying-Chen Lu, “Lactobacillus Isolates Having Anti-Inflammatory Activities and Uses of the Same (GMNL-89)” EP10191326.7
  30. (發明) Ying-Chen Lu, and Ching-Hsiang Hsu, “COMPOSITION AND USE OF LACTOBACILLUS PARACASEI STRAIN GMNL-133 IN TREATING ATOPIC DERMATITIS OR OTHER ALLERGIC DISEASES”, EP11185212.5 
  31. (發明) Ying-Chen Lu, and Ching-Hsiang Hsu, “COMPOSITION AND USE OF LACTOBACILLUS PARACASEI STRAIN GMNL-133 IN TREATING ATOPIC DERMATITIS OR OTHER ALLERGIC DISEASES”, CN 
  32. (發明) Ying-Chen Lu,  Jau-Shyang Huang, Ching-Hsiang Hsu, Yi-Cheng Li, Chia-Lin Lee, “Composition and use of probiotic strain GM-263 (ADR-1) in treating renal fibrosis in diabetes.” JP2011-19444 
  33. (發明) Ying-Chen Lu,  Jau-Shyang Huang, Ching-Hsiang Hsu, Yi-Cheng Li, Chia-Lin Lee, “Composition and use of probiotic strain GM-263 (ADR-1) in treating renal fibrosis in diabetes.” US13/006,432 
  34. (發明) 俞篤文、李濬笙、謝豐欽、陳靚珮、黃璻尹、呂英震,具有抗發炎活性的乳桿菌分離株及其用途(GMNL-76),TW100116515 
  35. (發明) 呂英震、謝豐欽,副乾酪乳酸桿菌株GM-133用於改善異位性皮膚炎或其他過敏疾病之組合物及其用途, TW100137219 
  36. (發明) 呂英震、謝豐欽、蔡政志、黃志楊、王雪芳、曾千育,益生菌株GM-080用於治療心臟發炎與心臟細胞凋亡之組合物及其用途,TW99129548

技術移轉
  1. 大豆香米優格生產技術
  2. 益嘉生技-優格產製技術
  3. 解憂酵素產製技術
  4. 抑制碳青黴烯類抗藥性肺炎克雷伯氏菌之鼠李糖乳桿菌

參與國際研討會壁報張貼 (ISMAB2018國際研討會壁報張貼資訊)
  1. Green tea powder improves probiotic viability in functional yogurt and provide added physicochemical benefits
  2. Selecting and identifying lactic acid bacteria in sourdough and their effect on sourdough physical and chemical properties
  3. Use of Lactobacillus brevis LUC247 fermented different content of quinoa sourdough to enrich with γ-aminobutyric acid (GABA)
  4. Effect of Momordica charantia L. on the growth and bacteriocin production of Lactobacillus gasseri LYC400
  5. Development of novel pineapple peel juice through lactic acid fermentation for enhancing antioxidant capacity and stability

SBIR產學合作計畫 SBIR Industry-Academia Cooperations
1.NG蝦乾燥技術與產品開發(SBIR)
2.開發新穎降血糖乳酸蔬果酵素及其抗氧化功效之研究(SBIR)
3.運用蝦殼再製作並提煉成含高蝦紅素的調理蝦油探討(SBIR)
4.雲林海線地區新型蛋捲開發計畫(SBIR)
5.蝦米哇糕膨發休閒食品開發(SBIR)
6.開發益生菌發酵酸奶油產品(SBIR)
7.開發國產海藻多酚益生菌抗菌沐浴乳(SBIR)

一般產學合作計畫 Other Industry-Academia Cooperations
  1. 新穎花生發酵產品開發(主持人)
  2. 腸道菌相分析(主持人)
  3. 素食發酵飲品檢驗(主持人)
  4. 開發具抗發炎能力益生菌發酵鳳梨食品(主持人)
  5. 大豆香米優格試製計畫(主持人)
  6. 愛酵素微生物分析檢驗計畫(主持人)
  7. 風味優格開發計畫(主持人)
  8. 麵團黏彈性分析(主持人)
  9. 乳酸菌免疫細胞刺激能力分析(主持人)
  10. 益生菌功能分析研究(主持人)
  11. NG蝦產品開發計畫-研發商品1式(主持人)
  12. 益生菌發酵麵團消費者喜好性分析(主持人)
  13. 益生菌篩選鑑定計畫(主持人)
  14. 食品安全管制系統基礎訓練(主持人)
  15. 蔬果酵素成分分析計畫(主持人)
  16. 食品安全管制系統基礎訓練(主持人)
  17. 食品安全管制系統進階訓練(主持人)
  18. 橄欖酵素產品開發(主持人)
  19. 乳酸菌凝集力分析(主持人)
  20. 鳥魚子休閒食品開發(主持人)
  21. 21.111食品安全管制系統訓練(主持人)
  22. 22.111食品安全管制系統訓練專班(主持人)
  23. 23.木虌果保健食品開發計畫(主持人)
  24. 24.曜楊益生菌(生沅)飼料添加配方對雞隻之影響(共同主持人)
  25. 25.開發生產無抗生素之安心冷凍或常溫之滴雞精(共同主持人)
  26. 26.研發生產中草藥及複方滴雞精(共同主持人)
  27. 27.研發愛嘉雞之相關產品加工(共同主持人)
  28. 28.開發生產純素飼糧及愛嘉雞之加工產品(共同主持人)

國科會計畫 NSTC Projects
  1. 篩選肉骨粉分解菌經固態發酵後促進肉雞生長之探討(1/3) (共同主持人)
  2. 篩選肉骨粉分解菌經固態發酵後促進肉雞生長之探討(2/3) (共同主持人)
  3. 篩選肉骨粉分解菌經固態發酵後促進肉雞生長之探討(3/3) (共同主持人)
  4. 生技機能性原料試量產製程技術聯盟(1/3) (共同主持人)
  5. 生技機能性原料試量產製程技術聯盟(2/3) (共同主持人)
  6. 生技機能性原料試量產製程技術聯盟(3/3) (共同主持人)
  7. 生技機能性原料試量產製程技術聯盟(II)(1/3) (共同主持人)
  8. 生技機能性原料試量產製程技術聯盟(II)(2/3) (共同主持人)
  9. 生技機能性原料試量產製程技術聯盟(II)(3/3) (共同主持人)
  10. 產學合作計畫-產業升級創新平台輔導計畫(協助傳統產業技術開發計畫 )-機能性有機大豆優格產品開發量產計畫 (主持人)


其他政府計劃 Other Government Projects
中小企業即時技術輔導計畫

其他論文研究 (2023)
申請大專生計畫並通過3名。
指導碩士學生完成論文48人,博士學生完成論文2人。

證書
食品安全管制系統基礎訓練合格
食品安全管制系統進階訓練合格
特定化學物質作業主管安全衛生教育訓練結業證書